APA (7th ed.) Citation

Çelik, S., Karabulut, Z. T., Selim, C., Çiftçiler, R., Yıldız, A., Yaman, S., . . . Kurt Yüksel, M. (2026). Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety. Journal of Clinical Medicine, 15(2), 634. https://doi.org/10.3390/jcm15020634

Chicago Style (17th ed.) Citation

Çelik, Serhat, et al. "Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety." Journal of Clinical Medicine 15, no. 2 (2026): 634. https://doi.org/10.3390/jcm15020634.

MLA (9th ed.) Citation

Çelik, Serhat, et al. "Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety." Journal of Clinical Medicine, vol. 15, no. 2, 2026, p. 634, https://doi.org/10.3390/jcm15020634.